Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.
Expert Opin Pharmacother. 2017 Jan 13;:
Authors: Eskazan AE
PMID: 28085518 [PubMed - as supplied by publisher]
http://ift.tt/2jIy7e9
Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.
Expert Opin Pharmacother. 2017 Jan 13;:
Authors: Eskazan AE
PMID: 28085518 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου